InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,843.60
(
-0.01%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
85.79
(
-0.83%
)
Bitcoin
57,504.10
(
2.97%
)
Post# of 252505
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: AlpineBV_Miller post# 44366

Thursday, 04/05/2007 11:14:25 AM

Thursday, April 05, 2007 11:14:25 AM

Post# of 252505
David,

After reading Adam's column, I am curious if your companies interest in ViRexx is because of OvaRex being an immunotherapy or is this a pick of Allen's (I believe he did the interview)?

I don't think much of ViRexx after the bad OvaRex "licensing" deal late last year and the huge dilution this year (I am long UTHR) but I think OvaRex has a chance if Placebo is anywhere below 14 months or so.

I'd be curious on your thoughts on OvaRex and in general on immunotherapies or do I need to be a subscriber for that :)?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up